Sherwin-Williams (NYSE:SHW) Given New $380.00 Price Target at Wells Fargo & Company

Sherwin-Williams (NYSE:SHWGet Free Report) had its target price decreased by stock analysts at Wells Fargo & Company from $400.00 to $380.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 14.49% from the stock’s previous close.

SHW has been the subject of several other research reports. JPMorgan Chase & Co. upped their target price on shares of Sherwin-Williams from $370.00 to $390.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Royal Bank of Canada lowered their price objective on shares of Sherwin-Williams from $438.00 to $415.00 and set an “outperform” rating for the company in a research report on Monday, February 3rd. Jefferies Financial Group reaffirmed a “hold” rating and set a $380.00 price objective (down previously from $423.00) on shares of Sherwin-Williams in a research note on Monday, March 10th. Berenberg Bank raised Sherwin-Williams from a “hold” rating to a “buy” rating and boosted their target price for the company from $321.00 to $420.00 in a research note on Friday, January 24th. Finally, Zelman & Associates raised Sherwin-Williams to a “strong-buy” rating in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Sherwin-Williams presently has a consensus rating of “Moderate Buy” and an average price target of $398.94.

Read Our Latest Research Report on SHW

Sherwin-Williams Stock Performance

SHW stock opened at $331.91 on Thursday. The company has a quick ratio of 0.46, a current ratio of 0.79 and a debt-to-equity ratio of 2.02. Sherwin-Williams has a twelve month low of $282.09 and a twelve month high of $400.42. The business’s fifty day moving average is $352.24 and its 200-day moving average is $362.90. The company has a market cap of $83.48 billion, a P/E ratio of 31.46, a price-to-earnings-growth ratio of 2.98 and a beta of 1.23.

Sherwin-Williams (NYSE:SHWGet Free Report) last issued its earnings results on Thursday, January 30th. The specialty chemicals company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same quarter in the previous year, the company earned $1.81 EPS. Equities research analysts forecast that Sherwin-Williams will post 12 EPS for the current year.

Insider Activity at Sherwin-Williams

In related news, insider Colin M. Davie sold 2,799 shares of the stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $360.30, for a total transaction of $1,008,479.70. Following the completion of the transaction, the insider now directly owns 5,365 shares of the company’s stock, valued at approximately $1,933,009.50. This represents a 34.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in SHW. Legacy Capital Wealth Partners LLC grew its stake in shares of Sherwin-Williams by 2.9% in the fourth quarter. Legacy Capital Wealth Partners LLC now owns 1,028 shares of the specialty chemicals company’s stock valued at $350,000 after buying an additional 29 shares in the last quarter. Apella Capital LLC grew its position in shares of Sherwin-Williams by 2.1% in the 4th quarter. Apella Capital LLC now owns 1,465 shares of the specialty chemicals company’s stock valued at $498,000 after acquiring an additional 30 shares during the period. Atlantic Edge Private Wealth Management LLC increased its stake in shares of Sherwin-Williams by 0.8% during the 4th quarter. Atlantic Edge Private Wealth Management LLC now owns 3,742 shares of the specialty chemicals company’s stock worth $1,272,000 after purchasing an additional 30 shares during the last quarter. IMS Capital Management raised its holdings in shares of Sherwin-Williams by 2.4% in the 4th quarter. IMS Capital Management now owns 1,287 shares of the specialty chemicals company’s stock valued at $437,000 after purchasing an additional 30 shares during the period. Finally, Coppell Advisory Solutions LLC lifted its stake in Sherwin-Williams by 2.7% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,146 shares of the specialty chemicals company’s stock valued at $388,000 after purchasing an additional 30 shares during the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

About Sherwin-Williams

(Get Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Featured Stories

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.